A detailed history of Cresset Asset Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 16,716 shares of URGN stock, worth $171,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,716
Previous 16,716 -0.0%
Holding current value
$171,171
Previous $280,000 24.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.72 - $19.2 $1,691 - $2,553
-133 Reduced 0.79%
16,716 $280,000
Q1 2024

May 15, 2024

BUY
$13.81 - $19.33 $1,836 - $2,570
133 Added 0.8%
16,849 $252,000
Q3 2023

Nov 14, 2023

SELL
$8.84 - $22.64 $4,216 - $10,799
-477 Reduced 2.77%
16,716 $234,000
Q2 2023

Aug 14, 2023

BUY
$8.75 - $14.29 $150,438 - $245,687
17,193 New
17,193 $177,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $233M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.